SS Innovations International (SS Innovations International) Interest Expense : $-0.62 Mil (TTM As of Mar. 2024)

View and export this data going back to 2018. Start your Free Trial

What is SS Innovations International Interest Expense?

Interest Expense is the amount reported by a company or individual as an expense for borrowed money. SS Innovations International's interest expense for the three months ended in Mar. 2024 was $ -0.18 Mil. Its interest expense for the trailing twelve months (TTM) ended in Mar. 2024 was $-0.62 Mil.

Interest Coverage is a ratio that determines how easily a company can pay interest expenses on outstanding debt. It is calculated by dividing a company's Operating Income(EBIT) by its Interest Expense. SS Innovations International's Operating Income for the three months ended in Mar. 2024 was $ -2.72 Mil. SS Innovations International's Interest Expense for the three months ended in Mar. 2024 was $ -0.18 Mil. SS Innovations International did not have earnings to cover the interest expense. The higher the ratio, the stronger the company's financial strength is. Note: If both Interest Expense and Interest Income are empty, while Net Interest Income is negative, then use Net Interest Income as Interest Expense.

SS Innovations International Interest Expense Historical Data

The historical data trend for SS Innovations International's Interest Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

SS Innovations International Interest Expense Chart

SS Innovations International Annual Data

Trend

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Interest Expense

Get a 7-Day Free Trial

-0.02

-0.16

-0.52

SS Innovations International Quarterly Data
	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
Interest Expense	Get a 7-Day Free Trial															-0.03	-0.09	-0.01	-0.34	-0.18

SS Innovations International Interest Expense Calculation

Interest Expense is the amount reported by a company or individual as an expense for borrowed money.

Interest Expense for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was $-0.62 Mil.

SS Innovations International (OTCPK:SSII) Interest Expense Explanation

Note: If both Interest Expense and Interest Income are empty, while Net Interest Income is negative, then use Net Interest Income as Interest Expense.

SS Innovations International's Interest Expense for the three months ended in Mar. 2024 was $-0.18 Mil. Its Operating Income for the three months ended in Mar. 2024 was $-2.72 Mil. And its Long-Term Debt & Capital Lease Obligation for the three months ended in Mar. 2024 was $1.85 Mil.

SS Innovations International's Interest Coverage for the quarter that ended in Mar. 2024 is calculated as

SS Innovations International did not have earnings to cover the interest expense.

The higher the ratio, the stronger the company's financial strength is.

SS Innovations International (SS Innovations International) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » SS Innovations International Inc (OTCPK:SSII) » Definitions » Interest Expense

Comparable Companies

Traded in Other Exchanges

N/A

Address

1500 SE 15th Street, Suite 512, Fort Lauderdale, FL, USA, 33316

Website

https://www.ssinnovations.com

SS Innovations International Inc, formerly Avra Medical Robotics Inc develops medical-surgical devices. It invests in four areas including surgical robotic systems, surgical tools, implantable devices, and surgical robotic training. It is a medical robotics company developing a fully autonomous medical robotic system using proprietary software which integrates Artificial Intelligence and Deep Learning, or machine learning. By using an AI and DL-enhanced software program, the company is creating an intelligent robotic system that it believes can robotize a wide range of medical procedures currently being performed by human hands.

Executives

Barry F Cohen	director, officer: COO	1600 SOUTHEAST 15TH STREET, APT 512, FORT LAUDERDALE FL 33316
Sudhir Srivastava	director, 10 percent owner, officer: Chairman and CEO	C/O AVRA SURGICAL ROBOTICS, ONE LIBERTY PLAZA, 35TH FLOOR, NEW YORK NY 10006
Kumar Sethi Anup	officer: Chief Financial Officer	C-102, DREAM APARTMENTS,, PLOT-14, SECTOR 22, DWARKA, NEW DEHLI K7 110077
Pascual Srivastava Vishwajyoti	officer: President	28 HAARBAA, TRIAVENI GARDENS COMPLEX, GADAIPUR MEHRA, NEW DEHLI K7 110030
Sampige Prasannakumar Somashekar	director	APT 9J, NEST NO 8, 303 LG HALFI, RMV II, BANGALORE K7 560094
Annadurai Mylswamy	director	#344, NTI LAYOUT, 10TH MAIN, VIDHYARANYAPURA, BANGALORE K7 560067